BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Oct 5, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-10-03

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-03	Common Stock	M	2500	$11.05	Acquired	38955	Direct
2011-10-03	Common Stock	S	2500	$31.0026	Disposed	36455	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-03	Stock Option (right to buy)	$11.05	M	2500	Disposed	2019-03-01	Common Stock (2500)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 9, 2011.

F2: The range of sales prices received was $30.28 to $31.91. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

F3: Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter.